Review Shows Mixed Findings on GLP-1 RAs and Suicidal Behaviors Tags GLP-1 agonists Read more about Review Shows Mixed Findings on GLP-1 RAs and Suicidal Behaviors
Case of Probable Metformin-Induced Erythema Multiforme in Type 2 Diabetes Mellitus Tags ORAL GTT hBA1c Long acting Biguanide Read more about Case of Probable Metformin-Induced Erythema Multiforme in Type 2 Diabetes Mellitus
GLP-1 RA Use Not Associated With Increased Safety Risks in OUD Tags GLP-1 agonists Read more about GLP-1 RA Use Not Associated With Increased Safety Risks in OUD
CSII and AID Associated With Improved Glycemic Outcomes in Pediatric T1DM Tags Insulin syringes Others Delivery devices hBA1c Read more about CSII and AID Associated With Improved Glycemic Outcomes in Pediatric T1DM
Semaglutide Added to Insulin Improved Glycemic, Renal Measures in T2DM Tags Diabetic Nephropathy FBS GLP-1 agonists hBA1c Read more about Semaglutide Added to Insulin Improved Glycemic, Renal Measures in T2DM
SGLT2 Inhibitors Did Not Worsen LUTS in Type 2 Diabetes Tags Diabetic Nephropathy SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Did Not Worsen LUTS in Type 2 Diabetes
SGLT2i Associated With Lower HHF, CV Death Risk in PAD Tags Coronary artery disease Peripheral vascular disease SGLT-2 Inhibitor Read more about SGLT2i Associated With Lower HHF, CV Death Risk in PAD
Orforglipron Demonstrated Dose-Dependent GI Adverse Events Tags GLP-1 agonists Read more about Orforglipron Demonstrated Dose-Dependent GI Adverse Events
SGLT2 Inhibitors Not Linked to Higher UTI Risk After Ileal Urinary Diversion Tags Diabetic Nephropathy SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Not Linked to Higher UTI Risk After Ileal Urinary Diversion
Orforglipron Shows Dose-Related GI Adverse Events Tags GLP-1 agonists Read more about Orforglipron Shows Dose-Related GI Adverse Events